Just how important is it to understand how much you’re spending on sales and marketing and where exactly that money is going? According to Stewart Adkins, Director of Stewart Adkins Advisors, Ltd., nothing could be more important right now. (11/20/2007)

As David Impey, consultant for BigBear Communications points out, the environments for direct to consumer advertising (DTCA) in Europe and in the United States are very different. (11/20/2007)

A group of top pharmaceutical companies have teamed up to develop diagnostic tests to identify patients at risk of dangerous adverse drug reactions. The Serious Adverse Events Consortium (SAEC), which includes Abbott, GlaxoSmithKline, Johnson & Johnson, Pfizer, Roche, sanofi-aventis and Wyeth, will begin by searching for genetic links to severe liver toxicity and the dangerous skin condition known as Stevens-Johnson syndrome. (11/20/2007)

Most would agree that the pharma industry needs to change its sales model, but how should companies go about doing it? (10/29/2007)

How can companies motivate and retain their stellar staff? (10/29/2007)

The message that starts at the top of an organisation is rarely the one that emerges at street level, but there are ways of aligning the two (10/29/2007)

Wireless technologies including 3G are now part and parcel of the working lives of Pfizer’s sales reps (10/29/2007)

Why SFE initiatives fail, and what can be done about it (10/29/2007)

In today’s highly competitive market for physician time and attention, many pharmaceutical companies consider it a mark of success if they can increase their sales representatives’ average time with targeted physicians from 1.5 minutes to 2. This statistic speaks volumes about the poverty of interactions between most reps and the physicians they call on. (10/29/2007)

Adaptive clinical trials have the potential to lower cost, reduce time to market and increase patient safety. (10/30/2007)